| DGEFX | SFGCX | DGEFX / SFGCX | |
| Total Expense Ratio | 0.94 | 1.92 | 49% |
| Annual Report Gross Expense Ratio | 1.07 | 2.28 | 47% |
| Fund Existence | 9 years | 27 years | - |
| Gain YTD | 2.115 | 2.194 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 487M | 48.6M | 1,002% |
| Annual Yield % from dividends | 1.92 | 1.40 | 138% |
| Returns for 1 year | 14.97 | 7.88 | 190% |
| Returns for 3 years | 30.48 | 20.35 | 150% |
| Returns for 5 years | 55.51 | -1.56 | -3,557% |
| Returns for 10 years | N/A | 45.26 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TSLQ | 18.21 | 0.14 | +0.77% |
| Tradr 2X Short TSLA Daily ETF | |||
| GENM | 10.38 | 0.02 | +0.19% |
| Genter Capital Municipal Qual Interm ETF | |||
| FFEB | 57.11 | -0.03 | -0.06% |
| FT Vest US Equity Buffer ETF Feb | |||
| BGRO | 39.05 | -0.05 | -0.14% |
| iShares Large Cap Growth Active ETF | |||
| BBP | 80.14 | -0.45 | -0.56% |
| Virtus LifeSci Biotech Products ETF | |||